- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- August 2025
- 150 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- January 2026
- 160 Pages
Global
From €3030EUR$3,358USD£2,633GBP
€3565EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,155USD£3,147GBP
- Report
- November 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 92 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- June 2025
- 90 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- November 2025
- 500 Pages
Global
From €3605EUR$3,995USD£3,132GBP
- Report
- February 2026
- 200 Pages
United States
From €2698EUR$2,990USD£2,344GBP
- Report
- February 2026
- 150 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2025
- 150 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2025
- 150 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- December 2025
- 150 Pages
United States
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 84 Pages
Asia Pacific
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 86 Pages
Middle East
From €4377EUR$4,850USD£3,803GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more